The University of Maryland, Baltimore (UMB) received a $248,915 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The funding will support a 3-year research project to unravel the role of epigenetics and cytokines in type 2 diabetes among African-ancestry populations. The award aims to advance scientific understanding of the molecular mechanisms underlying this critical health disparity. UMB, a major public research university, will leverage its expertise in biomedical research to conduct the proposed investigations, which span basic science, translational research, and clinical studies. This grant award exemplifies NIDDK's commitment to funding innovative, interdisciplinary research to address complex medical challenges and improve prevention, diagnosis, and treatment of diabetes and related conditions.
Generated 3/4/25, 7:55 AM